Search Results
Dr. O'Neil Discusses Napabucasin With FOLFIRI and Bevacizumab in CRC
Dr. O'Neil on Next Steps for Napabucasin With FOLFIRI and Bevacizumab in CRC
TRIBE-2: FOLFOX or FOLFIRI With Bevacizumab in mCRC
Dr. Mizrahi on Bevacizumab as a Chemoprotectant in CRC
Dr. Bekaii-Saab Discusses an Analysis of Bevacizumab or Cetuximab for CRC
Dr. Saab on Napabucasin (BBI-608) in Colorectal Cancer Treatment
Dr. Muro Discusses Safety Data from Asian XELIRI Project in CRC
Understanding your treatment: Folfiri +/- Avastin therapy
Aflibercept plus FOLFIRI in Polish patients with metastatic colorectal cancer
Dr. Bekaii-Saab Discusses an Analysis of Bevacizumab or Cetuximab for CRC
GC11474 Napabucasin 83280-65-3
Dr. Bekaii-Saab on Napabucasin in Patients With Pancreatic Cancer
